NY-PVH
12.2.2016 09:01:06 CET | Business Wire | Press release
Tommy Hilfiger, which is owned by PVH Corp. [NYSE:PVH], has announced the next step in its strategy to democratize the runway and keep the consumer at the center of its business. Starting with the Spring 2017 NYFW season, Tommy Hilfiger will redirect its runway investment to align with the retail calendar and debut its Fall 2016 collections with a full-scale fashion show for consumers and press. The collection will be immediately available to purchase across all sales channels, including throughout the business’s retail partner network globally. This change channels the global power, influence and visibility of the brand’s NYFW shows to deliver consumers instant “Buy Now. Wear Now.” gratification.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160212005176/en/
The brand’s September show will mark the public debut of Gigi Hadid’s capsule collaboration with Tommy Hilfiger , where the complete TommyXGigi collection will be presented to consumers for the first time at a runway event in the brand’s signature entertaining show style. The presentation will also include an exclusive selection of looks curated from the extensive world of Tommy Hilfiger women’s, and the launch will be supported by an integrated global advertising campaign. The company will partner with a global multi-media broadcast network to amplify the fusion of fashion and entertainment that has long been at the heart of the brand’s DNA.
“I founded my brand to be accessible and inclusive, and I’ve always considered the consumer to be the most important aspect of our business,” said Tommy Hilfiger. “In the past 30 years, we’ve paved the way in fusing fashion and entertainment. This philosophy has always been a part of my dream to connect our global consumers to inspiring, unexpected fashion experiences. We’ve been building towards this for a long time, and the natural progression of this approach to democratizing the runway is to make the full excitement and energy of NYFW directly accessible to our consumers in a globally impactful way.”
Following the transition for Fall 2016 with the launch of the TommyXGigi capsule collection, the Spring 2017 Tommy Hilfiger women’s collections will debut to consumers for the first time in February 2017. In recognition of the current calendars for wholesale buyers and long-lead media, in September 2016 Tommy Hilfiger will stage private advance showings of the upcoming Spring 2017 collections.
The shift in Tommy Hilfiger’s women’s fashion show strategy reflects the company’s commitment to the global growth of its womenswear business. Supported by a highly engaged audience around the Tommy Hilfiger women’s show and NYFW, there is a strong potential for additional growth across all women’s categories.
“As one of the world’s most recognized American lifestyle brands and most visible shows at NYFW, we have a unique opportunity to take a leadership role in moving the runway closer to the consumer,” said Daniel Grieder, Chief Executive Officer for Tommy Hilfiger. “In line with our vision to become more consumer centric, it’s important that we channel the incredible visibility and engagement that our shows generate into the moment when the product launches. This is the next step in our journey to shorten the development cycle and balance our approach to meet the diverse needs of consumers, buyers and media. We are committed to working in a new way with our business partners and the industry to achieve this goal.”
The approach signifies a new era of agility for Tommy Hilfiger that will bring it closer to consumers and provide greater flexibility in adapting to the needs and preferences of a changing market. Further details will be revealed in the lead-up to the brand’s September 2016 runway show.
# # #
About Tommy Hilfiger
With a brand portfolio that includes Tommy Hilfiger and Hilfiger Denim , Tommy Hilfiger is one of the world’s most recognized premium designer lifestyle groups. Its focus is designing and marketing high-quality men’s tailored clothing and sportswear, women’s collection apparel and sportswear, kidswear, denim collections, underwear (including robes, sleepwear and loungewear), footwear and accessories. Through select licensees, Tommy Hilfiger offers complementary lifestyle products such as eyewear, watches, fragrance, athletic apparel (golf and swim), socks, small leather goods, home goods and luggage. The Hilfiger Denim product line consists of jeanswear and footwear for men and women, accessories, and fragrance. Merchandise under the Tommy Hilfiger and Hilfiger Denim brands is available to consumers worldwide through an extensive network of Tommy Hilfiger and Hilfiger Denim retail stores, leading specialty and department stores, select online retailers, and at tommy .com.
About PVH
PVH Corp., one of the world’s largest apparel companies, owns and markets the iconic Calvin Klein and Tommy Hilfiger brands worldwide. It is the world’s largest shirt and neckwear company and markets a variety of goods under its own brands, Van Heusen , Calvin Klein , Tommy Hilfiger , IZOD , ARROW , Warner’s and Olga, and its licensed brands, including Speedo , Geoffrey Beene , Kenneth Cole New York , Kenneth Cole Reaction , MICHAEL Michael Kors , Sean John , and Chaps .
View source version on businesswire.com: http://www.businesswire.com/news/home/20160212005176/en/
Contact:
Tommy Hilfiger
Americas:
Abdel El Hamri, +1 212 548 1728
Senior
Vice President, Marketing & Communications, the Americas
Abdel.ElHamri@tommy.com
or
Asia
Pacific:
Eric Reed, +852 3916 1336
Vice President, Marketing &
Communications
eric.reed@tommy.com
or
Europe:
Kimberley
Witcomb, +31 (0) 20 709 5714
Director of Communications, EMEA
Kimberley.Witcomb@tommy.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
